Thank you for visiting Gilead.com. Please explore this section for the latest news about Gilead, our groundbreaking research and our therapeutics.

Please see Gilead-at-a-Glance to learn more about the company and our portfolio of products.

Sign-up to receive email alerts whenever new company information is posted to the site.

Recent News

May 7, 2008
Gilead Appoints John C. Martin as Chairman of Board of Directors; Names John F. Milligan President

May 1, 2008
Gilead Initiates Letairis(R) (ambrisentan) Phase IV Program

April 25, 2008
European Commission Approves Viread(R) for Chronic Hepatitis B

April 24, 2008
Gilead Sciences to Present at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30

April 24, 2008
Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B

April 21, 2008
Robin L. Washington to Join Gilead as Senior Vice President and Chief Financial Officer

April 16, 2008
Gilead Sciences Announces First Quarter 2008 Financial Results

April 9, 2008
Gilead Sciences to Release First Quarter 2008 Financial Results on Wednesday, April 16, 2008